Tags

Type your tag names separated by a space and hit enter

Falsified antimalarials: a minireview.
Expert Rev Anti Infect Ther 2015; 13(4):505-9ER

Abstract

Malaria is a curable disease, provided timely access to efficacious drugs is sought. Poor quality and, in particular, falsified antimalarial drugs harm the population of malaria endemic areas; they put lives in peril, cause economic losses to patients, families, industry, and generally undermine the trust in health systems. The extent of the problem is not easily assessed, and although a prevalence of up to 35% of poor-quality antimalarials has been reported, this number should be interpreted with caution given the heterogeneity of methods used to measure it. The trade in falsified antimalarials can be curtailed by putting in place drug quality surveillance, better legislation and improving the access and affordability of these essential drugs.

Authors+Show Affiliations

Department of Internal Medicine, Clinica Universidad de Navarra, Pamplona 31008, Spain.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

25683870

Citation

Chaccour, Carlos, et al. "Falsified Antimalarials: a Minireview." Expert Review of Anti-infective Therapy, vol. 13, no. 4, 2015, pp. 505-9.
Chaccour C, Kaur H, Del Pozo JL. Falsified antimalarials: a minireview. Expert Rev Anti Infect Ther. 2015;13(4):505-9.
Chaccour, C., Kaur, H., & Del Pozo, J. L. (2015). Falsified antimalarials: a minireview. Expert Review of Anti-infective Therapy, 13(4), pp. 505-9. doi:10.1586/14787210.2015.1015990.
Chaccour C, Kaur H, Del Pozo JL. Falsified Antimalarials: a Minireview. Expert Rev Anti Infect Ther. 2015;13(4):505-9. PubMed PMID: 25683870.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Falsified antimalarials: a minireview. AU - Chaccour,Carlos, AU - Kaur,Harparkash, AU - Del Pozo,Jose Luis, Y1 - 2015/02/15/ PY - 2015/2/17/entrez PY - 2015/2/17/pubmed PY - 2015/12/15/medline KW - antimalarials KW - artemisinin KW - artesunate KW - counterfeit drugs KW - falsified drugs KW - malaria KW - poor-quality drugs KW - substandard drugs SP - 505 EP - 9 JF - Expert review of anti-infective therapy JO - Expert Rev Anti Infect Ther VL - 13 IS - 4 N2 - Malaria is a curable disease, provided timely access to efficacious drugs is sought. Poor quality and, in particular, falsified antimalarial drugs harm the population of malaria endemic areas; they put lives in peril, cause economic losses to patients, families, industry, and generally undermine the trust in health systems. The extent of the problem is not easily assessed, and although a prevalence of up to 35% of poor-quality antimalarials has been reported, this number should be interpreted with caution given the heterogeneity of methods used to measure it. The trade in falsified antimalarials can be curtailed by putting in place drug quality surveillance, better legislation and improving the access and affordability of these essential drugs. SN - 1744-8336 UR - https://www.unboundmedicine.com/medline/citation/25683870/full_citation L2 - http://www.tandfonline.com/doi/full/10.1586/14787210.2015.1015990 DB - PRIME DP - Unbound Medicine ER -